Phillip M. Pierorazio
Johns Hopkins University School of Medicine
344 Papers
1K Citations
Phillip M. Pierorazio is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Medicine & Nephrectomy. The author has an hindex of 42, co-authored 273 publications. Previous affiliations of Phillip M. Pierorazio include Temple University & Columbia University Medical Center.
Chat about Author
Papers
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
Phillip M. Pierorazio,Brian M. Lin,Jeffrey K. Mullins,M. Eric Hyndman,Edward M. Schaeffer,Misop Han,Alan W. Partin,Christian P. Pavlovich +7 more
TL;DR: High-Gleason PC was not uniformly associated with poor outcomes after RP, though men with unfavorable (pT3b/N1) disease fared poorly.
5
Characterization of the macrophage infiltrate in a case of xanthogranulomatous pyelonephritis
TL;DR: The phenotypic characterization of the macrophage infiltrate in a case of XGP is reported and may form the basis of future non-invasive treatment strategies for XGP.
5
Chemoablation in Urothelial Carcinoma: A Systematic Review and Future Perspectives.
TL;DR: An overview of the evidence for intracavitary chemoablation in the treatment of urothelial carcinomas is provided and a novel mitomycin formulation has recently been approved for treating low-grade UTUC.
5
A prospective comparative study of routine versus deferred pelvic drain placement after radical prostatectomy: impact on complications and opioid use.
Mitchell M. Huang,Hiten D. Patel,Zhuo T. Su,Christian P. Pavlovich,Alan W. Partin,Phillip M. Pierorazio,Mohamad E. Allaf +6 more
TL;DR: Experienced surgeons may safely defer drain placement in the majority of robot-assisted RP cases, and there was no difference in adverse events, complications, symptomatic collections, or opioid use with deferral of routine drain placement after RP.
5
High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy.
Debebe Theodros,Benjamin Murter,John-William Sidhom,Thomas R. Nirschl,Thomas R. Nirschl,David J. Clark,Li Jun Chen,Ada J. Tam,Ada J. Tam,Richard L. Blosser,Richard L. Blosser,Zeyad Schwen,Michael H. Johnson,Phillip M. Pierorazio,Hui Zhang,Sudipto Ganguly,Sudipto Ganguly,Drew M. Pardoll,Jelani C. Zarif,Jelani C. Zarif +19 more
TL;DR: Evidence is provided, for the first time, of an immunosuppressive and pro-tumorigenic role of myeloid cells in early, clinically localized ccRCC.
5